Empowering life sciences dealmakers in service of patients. https://xitter.gq/t.co/xYbrTqb4Fh
San Francisco, CA
Joined May 2016
- Tweets275
- Following439
- Followers204
- Likes316
Novelty is a double-edged sword. It’s great to be novel, but the nature of novelty also makes it harder for the team at prospective partner companies to value your science.
Novel science requires mastering the scientific sale:
motionhall.com/casestudy/nov…
1
Most biotech licensing and partnering deals focus on a single asset, in only one specific indication. How should the leadership team of a platform company approach deal-making?
motionhall.com/casestudy/bui…
Interested to hear more from the @cnbc #HealthyReturns on how competitors are collaborating on COVID19 with @megtirrell.
2
During a recent Executive Call, Anton Gueth and MotionHall CEO Rachael Craig discuss the ins and outs of biopharma dealmaking in 2020 over video conference:
linkedin.com/pulse/leading-d…
1
Rachael and Chris cover:
- How are other leadership teams reacting?
- How are deals being impacted across venture, licensing and M&A?
- What will happen with valuations and deal structure?
- Where can we find optimism, opportunities and silver linings?
#biotech #COVID19
If you're wondering how biotech is being impacted both positively and negatively by the pandemic...
I had coffee with Xontogeny's Chris Garabedian to discuss biotech leadership and strategy in 2020, aka, biotech leadership during hard times.
tinyurl.com/umsujxt
1
From the MotionHall Executive Call Series: Anticipating & Planning for Biotech Deal Dynamics #biotech #pharma #licensing #MotionHall
linkedin.com/pulse/motionhal…
What's the best month of the year to close a licensing deal?
Hint... it's not August.
#biotech #pharma #licensing
0%October
50%November
50%December
0%January
2 votes • Final results 1
From the @motionhall Executive Call Series: "How can we best address new contacts and at the large pharmas, and cut through the noise in order to generate a productive response?"
linkedin.com/pulse/executive…
#licensing #biotech #pharma #motionhall #businessdevelopment
1
What goes into a successful #biotech out-licensing process? Quite possibly, more than you think:
linkedin.com/pulse/what-goes…
2
From the MotionHall Executive Call Series, "Making realistic and probable scenarios for strategic partnering and/or M&A is one approach to enhancing pre-market valuation for venture financing. How does MotionHall OutMatch perform?"
linkedin.com/pulse/motionhal…
1
There IS still time to plan and optimize your meetings at #JPM2020 Join us on Monday for a discussion of tips, tricks & strategies for biotech execs headed to San Francisco.
inside.motionhall.com/execut…
1
How can a thorough internal risk adjustment exercise help you in sell-side deal negotiations?
Find out by reviewing our latest executive call addressing Deal Modeling & Deal Structures produced specifically by leading biotech asset sellers for sellers.
linkedin.com/pulse/motionhal…
1
Growth-strategist and BioPharma industry native joins MotionHall to meet growing demand for the company’s AI-powered data platform for efficient BioPharma dealmaking.
prweb.com/releases/motionhal…
#pharma #artificialintelligence #biotech #technologynews
Should a partnering market forecast be considered in target selection and portfolio optimization?
motionhall.com/blog/when_sho…
#biotech #pharma #licensing #mergersandacquisitions
From MotionHall's Executive Call Series: How to Build a Solid Business Development (BD) Strategy -
linkedin.com/pulse/motionhal…
#biotech #pharma #licensing #artificialintelligence #businessdevelopment
When should my biotech consider licensing strategy? #biotech #partnering #licensing #pharma
linkedin.com/pulse/inside-mo…
1
motionhall retweeted
That's a wrap for #BIO2019 in Philly!
We can't wait to see you at #BIO2020 in California!
Details: convention.bio.org/2020/
Looking forward to meeting with company leaders across #biotech, #vc and #ibanking to talk biopharma bd optimization this BIO!
The biggest week in biotech & pharma is almost here! #BIO2019 will bring together 17,000+ global leaders for networking, BIO One-on-One Partnering, education and so much more. See you in Philadelphia!
1
Headed to #BIO2019? Maximize Your Biopharma Deal Value - If you are an emerging biotech company focusing on out-licensing, download your free, strategic-deal toolbook here: motionhall.com/blog/bd_strat…